This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fu, M., Sauve, A. A., Liu, M., Jiao, X., Zhang, X., Powell, M., Yang, T., Gu, W., Avantaggiati, M. L., Pattabiraman, N., Pestell, T. G., Wang, C., Wang, F., Quong, A., and Pestell, R. G. Hormonal control of androgen receptor function through SIRT1. Mol Biol Cell, 26: 8122–8135, 2006.
Yang, T., Fu, M., Pestell, R., and Sauve, A. A. SIRT1 and endocrine signaling. Trends Endocrinol Metab, 17: 186–191, 2006.
Leader, J. E., Wang, C., Fu, M., and Pestell, R. G. Epigenetic regulation of nuclear steroid receptors. Biochem Pharmacol, 2006.
Bevan, C. L., Hoare, S., Claessens, F., Heery, D. M., and Parker, M.G. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol, 19: 8383–8392, 1999.
Wang, L., Hsu, C. L., and Chang, C. Androgen receptor corepressors: an overview. Prostate, 63: 117–130, 2005.
Eberharter, A. and Becker, P. B. ATP-dependent nucleosome remodelling: factors and functions. J Cell Sci, 117: 3707–3711, 2004.
Chen, J., Kinyamu, H. K., and Archer, T. K. Changes in attitude, changes in latitude: nuclear receptors remodeling chromatin to regulate transcription. Mol Endocrinol, 20:1–13, 2006.
Fu, M., Wang, C., Wang, J., Zafonte, B. T., Lisanti, M. P., and Pestell, R. G. Acetylation in hormone signaling and the cell cycle. Cytokine Growth Factor Rev, 13: 259–276, 2002.
Wang, C., Fu, M., Angeletti, R. H., Siconolfi-Baez, L., Reutens, A. T., Albanese, C., Lisanti, M. P., Katzenellenbogen, B. S., Kato, S., Hopp, T., Fuqua, S. A., Lopez, G. N., Kushner, P. J., and Pestell, R. G. Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem, 276: 18375–18383, 2001.
Fu, M., Wang, C., Reutens, A. T., Wang, J., Angeletti, R. H., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M. L., and Pestell, R. G. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem, 275: 20853–20860, 2000.
Gaughan, L., Logan, I. R., Cook, S., Neal, D. E., and Robson, C. N. Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. J Biol Chem, 277: 25904–25913, 2002.
Fu, M., Wang, C., Wang, J., Sakamaki, T., Di Vizio, D., Zhang, X., Albanese, C., Balk, S., Chang, C., Fan, S., Rosen, E., Palvimo, J. J., Janne, O. A., Muratoglu, S., Avantaggiati, M., and Pestell, R. G. Acetylation of the androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol, 23: 8563–8575, 2003.
Gong, J., Zhu, J., Goodman, O. B., Pestell, R. G., Schlegel, P. N., Nanus, D. M., and Shen, R. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Oncogene, 25: 2011–2021, 2006.
Polesskaya, A., Naguibneva, I., Duquet, A., Bengal, E., Robin, P., and Harel-Bellan, A. Interaction between acetylated MyoD and the bromodomain of CBP and/or p300. Mol Cell Biol, 21: 5312–5320, 2001.
Fu, M., Wang, C., Wang, J., Sakamaki, T., Zhang, X., Yeung, Y.-G., Chang, C., Hopp, T., Fuqua, S. A. W., Jaffray, E., Hay, R. T., Palvimo, J. J., Jänne, O. A., and Pestell, R. G. The Androgen Receptor Acetylation governs transactivation and MEKK1-induced apoptosis without affecting in vitro sumoylation and transrepression function. Mol Cell Biol, 22: 3373–3388, 2002.
Fu, M., Rao, M., Wu, K., Wang, C., Zhang, X., Hessien, M., Yeung, Y. G., Gioeli, D., Weber, M. J., and Pestell, R. G. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. J Biol Chem, 279: 29436–29449, 2004.
Ananthaswamy, H. N., Ouhtit, A., Evans, R. L., Gorny, A., Khaskina, P., Sands, A. T., and Conti, C. J. Persistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis. Oncogene, 18: 7395–7398, 1999.
Debes, J. D., Sebo, T. J., Lohse, C. M., Murphy, L. M., Haugen de, A. L., and Tindall, D. J. p300 in prostate cancer proliferation and progression. Cancer Res, 63: 7638–7640, 2003.
Gregory, C. W., He, B., Johnson, R. T., Ford, O. H., Mohler, J. L., French, F. S., and Wilson, E. M. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res, 61: 4315–4319, 2001.
Metzger, E., Wissmann, M., Yin, N., Muller, J. M., Schneider, R., Peters, A. H., Gunther, T., Buettner, R., and Schule, R. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature, 437: 436–439, 2005.
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., and Shi, Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell, 119: 941–953, 2004.
Fu, M., Rao, M., Bouras, T., Wang, C., Wu, K., Zhang, X., Li, Z., Yao, T.-P., and Pestell, R. G. Cyclin D1 inhibits PPARgamma-mediated adipogenesis through HDAC recruitment. J Biol Chem, 280: 16934–16941, 2005.
Sauve, A. A. and Schramm, V. L. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates. Curr Med Chem, 11:807–826, 2004.
Kruszewski, M. and Szumiel, I. Sirtuins (histone deacetylases III) in the cellular response to DNA damage—facts and hypotheses. DNA Repair (Amst), 4: 1306–1313, 2005.
Tsukamoto, Y., Kato, J., and Ikeda, H. Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae. Nature, 388: 900–903, 1997.
Valencia, M., Bentele, M., Vaze, M. B., Herrmann, G., Kraus, E., Lee, S. E., Schar, P., and Haber, J. E. NEJ1 controls non-homologous end joining in Saccharomyces cerevisiae. Nature, 414: 666–669, 2001.
Frank-Vaillant, M. and Marcand, S. NHEJ regulation by mating type is exercised through a novel protein, Lif2p, essential to the ligase IV pathway. Genes Dev, 15: 3005–3012, 2001.
Jazayeri, A., McAinsh, A. D., and Jackson, S. P. Saccharomyces cerevisiae Sin3p facilitates DNA double-strand break repair. Proc Natl Acad Sci USA, 101: 1644–1649, 2004.
Tissenbaum, H. A. and Guarente, L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature, 410: 227–230, 2001.
Al-Regaiey, K. A., Masternak, M. M., Bonkowski, M., Sun, L., and Bartke, A. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. Endocrinology, 146: 851–860, 2005.
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., and Puigserver, P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature, 434: 113–118, 2005.
Grinspoon, S., Corcoran, C., Lee, K., Burrows, B., Hubbard, J., Katznelson, L., Walsh, M., Guccione, A., Cannan, J., Heller, H., Basgoz, N., and Klibanski, A. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab, 81: 4051–4058, 1996.
Schroeder, E. T., Terk, M., and Sattler, F. R. Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies. Am J Physiol Endocrinol Metab, 285: E16–24, 2003.
Altenberg, B. and Greulich, K. O. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics, 84: 1014–1020, 2004.
Chowdhury, S. K., Gemin, A., and Singh, G. High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines. Biochem Biophys Res Commun, 2005.
Baron, A., Migita, T., Tang, D., and Loda, M. Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem, 91: 47–53, 2004.
Rossi, S., Graner, E., Febbo, P., Weinstein, L., Bhattacharya, N., Onody, T., Bubley, G., Balk, S., and Loda, M. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res, 1: 707–715, 2003.
Seligson, D. B., Horvath, S., Shi, T., Yu, H., Tse, S., Grunstein, M., and Kurdistani, S. K. Global histone modification patterns predict risk of prostate cancer recurrence. Nature, 435: 1262–1266, 2005.
Vaquero, A., Scher, M., Lee, D., Erdjument-Bromage, H., Tempst, P., and Reinberg, D. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell, 16: 93–105, 2004.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press
About this chapter
Cite this chapter
Powell, M.J., Li, S., Lisanti, M.P., Nevalainen, M.T., Wang, C., Pestell, R.G. (2008). Epigenetic Modification and Acetylation of Androgen Receptor Regulate Prostate Cellular Growth. In: Pestell, R.G., Nevalainen, M.T., Milken, M. (eds) Prostate Cancer. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-60327-079-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-60327-079-3_7
Publisher Name: Humana Press
Print ISBN: 978-1-58829-741-9
Online ISBN: 978-1-60327-079-3
eBook Packages: MedicineMedicine (R0)